Key Symptom Domains to Be Assessed in Fibromyalgia (Outcome Measures in Rheumatoid Arthritis Clinical Trials)

被引：27
|
作者：
Choy, Ernest H. [1 ]
Mease, Philip J. [2 ,3 ]
机构：
[1] Kings Coll London, Weston Educ Ctr, Acad Dept Rheumatol, Sir Alfred Baring Garrod Clin Trials Unit, London SE5 9RJ, England
[2] Swedish Med Ctr, Div Rheumatol Res, Seattle, WA 98104 USA
[3] Univ Washington, Seattle, WA 98104 USA
来源：
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2009年 / 35卷 / 02期
关键词：
Fibromyalgia; Domains; Core data set; Assessment; Clinical trials; PAIN; PREVALENCE; DIAGNOSIS; CRITERIA; IMPACT;
D O I：
10.1016/j.rdc.2009.05.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This article discusses the key symptom domains to be assessed in fibromyalgia. Development of a consensus on a core set of outcome measures that should be assessed and reported in all clinical trials is needed to facilitate interpretation, pooling, and comparison of results. This aligns with the key objective of the Outcome Measures in Rheumatoid Arthritis Clinical Trials initiative to improve outcome measurement in rheumatic diseases through a data-driven interactive consensus process.
引用
下载
收藏
页码：329 / +
页数：10
相关论文
共 50 条
  • [21] Systematic Review of Discriminating Power of Outcome Measures Used in Clinical Trials of Fibromyalgia
    Carville, Serena F.
    Choy, Ernest H. S.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (11) : 2094 - 2105
  • [22] Outcome measures in rheumatoid arthritis randomised trials over the last 50 years
    Kirkham, Jamie J.
    Boers, Maarten
    Tugwell, Peter
    Clarke, Mike
    Williamson, Paula R.
    TRIALS, 2013, 14
  • [23] Outcome measures in rheumatoid arthritis randomised trials over the last 50 years
    Jamie J Kirkham
    Maarten Boers
    Peter Tugwell
    Mike Clarke
    Paula R Williamson
    Trials, 14
  • [24] OMERACT - CONCLUSIONS OF AN INTERNATIONAL-CONFERENCE ON OUTCOME MEASURES IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS IN MAASTRICHT
    BOERS, M
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S202 - S202
  • [25] Clinical trials are only as good as the patient- important outcome measures assessed
    不详
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2020, 125 : A7 - A9
  • [26] Comparison of rheumatoid arthritis clinical trial outcome measures - A simulation study
    Anderson, JJ
    Bolognese, JA
    Felson, DT
    ARTHRITIS AND RHEUMATISM, 2003, 48 (11): : 3031 - 3038
  • [27] Chronicity of rheumatoid arthritis affects the responsiveness of physical function, but not of disease activity measures in rheumatoid arthritis clinical trials
    Aletaha, Daniel
    Alasti, Farideh
    Smolen, Josef S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (03) : 532 - 537
  • [28] CHRONICITY OF RHEUMATOID ARTHRITIS AFFECTS THE RESPONSIVENESS OF PHYSICAL FUNCTION, BUT NOT OF DISEASE ACTIVITY MEASURES IN RHEUMATOID ARTHRITIS CLINICAL TRIALS
    Aletaha, D.
    Alasti, F.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 339 - 339
  • [29] Outcome measures in clinical trials
    Heyse, JF
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2004, 13 (02) : 87 - 87
  • [30] Responsiveness of fibromyalgia clinical trial outcome measures
    Dunkl, PR
    Taylor, AG
    McConnell, CG
    Alfano, AP
    Conaway, MR
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (11) : 2683 - 2691
12345